Shilpa Medicare (SHILPAMED): Press Release

Press Release Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy". Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Par

June 4, 2026 1 min read Shilpa Medicare

Press Release

Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy".

Disclaimer

This article is for informational purposes only and is not investment advice. Verify all figures and announcements from official exchange filings and company disclosures before making decisions.

All articles More on SHILPAMED

Track Indian stocks with ZTOX AI

View pricing

NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.

Real-time Updates

Filings and alerts in WhatsApp or Telegram

Smart Filtering

Focus on news that matter most to you

Start on the free plan

Track 5 companies at no cost. Upgrade anytime.

Track up to 50 Compnies

Insider deals notifications

Volume breakout detection (Purly informational)

Start Free Now